Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Hospitalized Non-critical COVID-19
NCT04423861Phase 3Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in coronavirus disease 2019 (COVID-19), sponsored by Azidus Laboratories Limited. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04423861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04423861.